Form 10-Q EASTMAN KODAK CO For: Mar 31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
For the quarterly period ended:
or
Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
For the transition period from to
Commission File Number
(Exact name of Registrant as specified in its charter)
(State or other jurisdiction of incorporation or organization) |
(IRS Employer Identification No.) |
|
|
(Address of principal executive offices) |
(Zip Code) |
(
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Common |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
|
|
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files).
Indicate by check mark whether the Registrant is a large, accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth" company in Rule 12b-2 of the Exchange Act.
Large accelerated filer |
|
☐ |
|
☒ |
|
|
Non-accelerated filer |
|
☐ |
|
Smaller reporting company |
|
|
Emerging growth company |
|
|
|
|
|
If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No
As of May 1, 2026, the Registrant had
EASTMAN KODAK COMPANY
Form 10-Q
March 31, 2026
Table of Contents
|
|
Page |
|
|
|
|
|
|
Item 1. |
2 |
|
|
2 |
|
|
3 |
|
|
4 |
|
|
5 |
|
|
6 |
|
|
7 |
|
Item 2. |
Management’s Discussion and Analysis of Financial Condition and Results of Operations |
25 |
|
32 |
|
Item 3. |
36 |
|
Item 4. |
36 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Item 1. |
37 |
|
Item 1A. |
37 |
|
Item 2. |
37 |
|
Item 3. |
37 |
|
Item 4. |
37 |
|
Item 5. |
37 |
|
Item 6. |
38 |
|
|
38 |
|
|
40 |
1
Part I. FINANCIAL INFORMATION
Item 1. Financial Statements
EASTMAN KODAK COMPANY
CONSOLIDATED STATEMENT OF OPERATIONS (Unaudited)
|
|
Three Months Ended |
|
|||||
|
|
March 31, |
|
|||||
(in millions, except per share data) |
|
2026 |
|
|
2025 |
|
||
Revenues |
|
|
|
|
|
|
||
Sales |
|
$ |
|
|
$ |
|
||
Services |
|
|
|
|
|
|
||
Total revenues |
|
|
|
|
|
|
||
Cost of revenues |
|
|
|
|
|
|
||
Sales |
|
|
|
|
|
|
||
Services |
|
|
|
|
|
|
||
Total cost of revenues |
|
|
|
|
|
|
||
Gross profit |
|
|
|
|
|
|
||
Selling, general and administrative expenses |
|
|
|
|
|
|
||
Research and development costs |
|
|
|
|
|
|
||
Restructuring costs and other |
|
|
|
|
|
|
||
Other operating expense, net |
|
|
|
|
|
|
||
Loss from operations before interest expense, pension |
|
|
( |
) |
|
|
( |
) |
Interest expense |
|
|
|
|
|
|
||
Pension income excluding service cost component |
|
|
( |
) |
|
|
( |
) |
Loss on early extinguishment of debt |
|
|
|
|
|
|
||
Other charges, net |
|
|
|
|
|
|
||
Loss from operations before income taxes |
|
|
( |
) |
|
|
( |
) |
Provision for income taxes |
|
|
|
|
|
|
||
NET LOSS |
|
$ |
( |
) |
|
$ |
( |
) |
|
|
|
|
|
|
|
||
Basic net loss per share attributable to Eastman Kodak Company |
|
$ |
( |
) |
|
$ |
( |
) |
Diluted net loss per share attributable to Eastman Kodak Company |
|
$ |
( |
) |
|
$ |
( |
) |
|
|
|
|
|
|
|
||
Number of common shares used in basic and diluted net loss per |
|
|
|
|
|
|
||
Basic |
|
|
|
|
|
|
||
Diluted |
|
|
|
|
|
|
||
The accompanying notes are an integral part of these consolidated financial statements.
2
EASTMAN KODAK COMPANY
CONSOLIDATED STATEMENT OF COMPREHENSIVE LOSS (Unaudited)
|
|
Three Months Ended |
|
|||||
|
|
March 31, |
|
|||||
(in millions) |
|
2026 |
|
|
2025 |
|
||
NET LOSS |
|
$ |
( |
) |
|
$ |
( |
) |
Other comprehensive income (loss), net of tax: |
|
|
|
|
|
|
||
Currency translation adjustments |
|
|
|
|
|
|
||
Pension and other postretirement benefit plan obligation activity, net of tax |
|
|
|
|
|
( |
) |
|
Other comprehensive income (loss), net of tax |
|
|
|
|
|
( |
) |
|
COMPREHENSIVE LOSS, NET OF TAX |
|
$ |
( |
) |
|
$ |
( |
) |
The accompanying notes are an integral part of these consolidated financial statements.
3
EASTMAN KODAK COMPANY
CONSOLIDATED STATEMENT OF FINANCIAL POSITION (Unaudited)
|
|
March 31, |
|
|
December 31, |
|
||
(in millions, except per share data) |
|
2026 |
|
|
2025 |
|
||
ASSETS |
|
|
|
|
|
|
||
Cash and cash equivalents |
|
$ |
|
|
$ |
|
||
Trade receivables, net of allowances of $ |
|
|
|
|
|
|
||
Inventories, net |
|
|
|
|
|
|
||
Other current assets |
|
|
|
|
|
|
||
Total current assets |
|
|
|
|
|
|
||
Property, plant and equipment, net of accumulated depreciation of $ |
|
|
|
|
|
|
||
Goodwill |
|
|
|
|
|
|
||
Intangible assets, net |
|
|
|
|
|
|
||
Operating lease right-of-use assets |
|
|
|
|
|
|
||
Restricted cash |
|
|
|
|
|
|
||
Pension and other postretirement assets |
|
|
|
|
|
|
||
Other long-term assets |
|
|
|
|
|
|
||
TOTAL ASSETS |
|
$ |
|
|
$ |
|
||
|
|
|
|
|
|
|
||
LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK AND EQUITY |
|
|
|
|
|
|
||
Accounts payable, trade |
|
$ |
|
|
$ |
|
||
Short-term borrowings and current portion of long-term debt |
|
|
|
|
|
|
||
Current portion of operating leases |
|
|
|
|
|
|
||
Other current liabilities |
|
|
|
|
|
|
||
Total current liabilities |
|
|
|
|
|
|
||
Long-term debt, net of current portion |
|
|
|
|
|
|
||
Pension and other postretirement liabilities |
|
|
|
|
|
|
||
Operating leases, net of current portion |
|
|
|
|
|
|
||
Other long-term liabilities |
|
|
|
|
|
|
||
Total liabilities |
|
|
|
|
|
|
||
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
||
Redeemable, convertible preferred stock, |
|
|
|
|
|
|
||
|
|
|
|
|
|
|
||
EQUITY |
|
|
|
|
|
|
||
|
|
|
|
|
|
|||
Additional paid in capital |
|
|
|
|
|
|
||
Treasury stock, at cost |
|
|
( |
) |
|
|
( |
) |
Accumulated deficit |
|
|
( |
) |
|
|
( |
) |
Accumulated other comprehensive loss |
|
|
( |
) |
|
|
( |
) |
Total shareholders’ equity |
|
|
|
|
|
|
||
TOTAL LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK AND EQUITY |
|
$ |
|
|
$ |
|
||
The accompanying notes are an integral part of these consolidated financial statements.
4
EASTMAN KODAK COMPANY
CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited)
|
|
Three Months Ended |
|
|||||
|
|
March 31, |
|
|||||
(in millions) |
|
2026 |
|
|
2025 |
|
||
Cash flows from operating activities: |
|
|
|
|
|
|
||
Net loss |
|
$ |
( |
) |
|
$ |
( |
) |
Adjustments to reconcile to net cash used in operating activities: |
|
|
|
|
|
|
||
Depreciation and amortization |
|
|
|
|
|
|
||
Pension and postretirement income |
|
|
|
|
|
( |
) |
|
Change in fair value of preferred stock embedded derivative |
|
|
|
|
|
— |
|
|
Non-cash changes in workers' compensation and employee benefit reserves |
|
|
— |
|
|
|
|
|
Stock based compensation |
|
|
|
|
|
|
||
Net gain from sale of assets |
|
|
( |
) |
|
|
|
|
Loss on early extinguishment of debt |
|
|
|
|
|
|
||
Provision for deferred income taxes |
|
|
|
|
|
|
||
Decrease (increase) in trade receivables |
|
|
|
|
|
( |
) |
|
(Increase) decrease in miscellaneous receivables |
|
|
( |
) |
|
|
|
|
Increase in inventories |
|
|
( |
) |
|
|
( |
) |
Increase in trade payables |
|
|
|
|
|
|
||
Decrease in liabilities excluding borrowings and trade payables |
|
|
( |
) |
|
|
( |
) |
Other items, net |
|
|
|
|
|
|
||
Total adjustments |
|
|
( |
) |
|
|
( |
) |
Net cash used in operating activities |
|
|
( |
) |
|
|
( |
) |
Cash flows from investing activities: |
|
|
|
|
|
|
||
Additions to properties |
|
|
( |
) |
|
|
( |
) |
Proceeds from sale of preferred equity investment |
|
|
|
|
|
|
||
Proceeds from redemption of KRIP reversion investments |
|
|
|
|
|
|
||
Net proceeds from the sale of assets |
|
|
|
|
|
|
||
Net cash provided by (used in) investing activities |
|
|
|
|
|
( |
) |
|
Cash flows from financing activities: |
|
|
|
|
|
|
||
Repayment of Amended and Restated Term Loan Agreement |
|
|
( |
) |
|
|
|
|
Preferred stock cash dividend payments |
|
|
( |
) |
|
|
( |
) |
Treasury stock purchases |
|
|
|
|
|
( |
) |
|
Net cash used in financing activities |
|
|
( |
) |
|
|
( |
) |
Effect of exchange rate changes on cash, cash equivalents and restricted cash |
|
|
( |
) |
|
|
|
|
Net decrease in cash, cash equivalents and restricted cash |
|
|
( |
) |
|
|
( |
) |
Cash, cash equivalents and restricted cash, beginning of period |
|
|
|
|
|
|
||
Cash, cash equivalents and restricted cash, end of period |
|
$ |
|
|
$ |
|
||
|
|
|
|
|
|
|
||
Non-cash Financing Item: |
|
|
|
|
|
|
||
Series B preferred stock embedded derivative liability at issuance |
|
$ |
|
|
$ |
|
||
The accompanying notes are an integral part of these consolidated financial statements.
5
EASTMAN KODAK COMPANY
CONSOLIDATED STATEMENT OF EQUITY (DEFICIT) (Unaudited)
|
|
Three-Month Period Ending March 31, 2026 |
|
|||||||||||||||||||||||||
|
|
Eastman Kodak Company Common Shareholders |
|
|
|
|
||||||||||||||||||||||
(in millions) |
|
Common |
|
|
Additional |
|
|
Accumulated |
|
|
Accumulated |
|
|
Treasury |
|
|
Total |
|
|
Redeemable |
|
|||||||
Equity (deficit) as of December 31, 2025 |
|
$ |
|
|
$ |
|
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
|
|
$ |
|
||||
Net loss |
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
— |
|
Other comprehensive income (net of tax): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Currency translation adjustments |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
||
Pension and other postretirement |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Extinguishment of |
|
|
— |
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
( |
) |
||
Issuance of |
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
|
|
Preferred stock cash dividends |
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
— |
|
Preferred stock deemed dividends |
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
|
|
Treasury stock purchases |
|
|
— |
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
— |
|
|
Stock-based compensation |
|
|
— |
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
— |
|
||
Equity (deficit) as of March 31, 2026 |
|
$ |
|
|
$ |
|
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
|
|
$ |
|
||||
|
|
Three-Month Period Ending March 31, 2025 |
|
|||||||||||||||||||||||||
|
|
Eastman Kodak Company Common Shareholders |
|
|
|
|
||||||||||||||||||||||
(in millions) |
|
Common |
|
|
Additional |
|
|
Accumulated |
|
|
Accumulated |
|
|
Treasury |
|
|
Total |
|
|
Redeemable |
|
|||||||
Equity (deficit) as of December 31, 2024 |
|
$ |
— |
|
|
$ |
|
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
|
|
$ |
|
|||
Net loss |
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
— |
|
Other comprehensive income (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Currency translation adjustments |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
||
Pension and other postretirement |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
|
|
— |
|
Preferred stock cash dividends |
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
— |
|
Preferred stock in-kind dividends |
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
|
|
Treasury stock purchases |
|
|
— |
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
( |
) |
|
|
|
||
Stock-based compensation |
|
|
— |
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
— |
|
||
Equity (deficit) as of March 31, 2025 |
|
$ |
— |
|
|
$ |
|
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
|
|
$ |
|
|||
The accompanying notes are an integral part of these consolidated financial statements.
6
EASTMAN KODAK COMPANY
NOTES TO FINANCIAL STATEMENTS (Unaudited)
NOTE 1: BASIS OF PRESENTATION AND RECENT ACCOUNTING PRONOUNCEMENTS
BASIS OF PRESENTATION
RECENTLY ADOPTED ACCOUNTING PRONOUNCEMENTS
No accounting pronouncements were recently adopted by Kodak.
RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS
In November 2024, the FASB issued ASU 2024-03, Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses. ASU 2024-03 requires public business entities to disclose specified information about certain costs and expenses, including but not limited to purchases of inventory, employee compensation, depreciation, and intangible asset amortization, in a tabular format within the notes to their financial statements, as well as provide additional disclosures related to certain other specified expenses. The ASU may be applied on either a prospective or retrospective basis and is effective for annual reporting periods beginning after December 15, 2026 (January 1, 2027 for Kodak) and interim reporting periods beginning after December 15, 2027 (January 1, 2028 for Kodak). Kodak is currently evaluating the impact of this ASU.
In September 2025, the FASB issued ASU 2025-06, Intangibles—Goodwill and Other— Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software. ASU 2025-06 modernizes the accounting for internal-use software to reflect the evolution of software development to using an incremental and iterative development method. Accordingly, the ASU removes all references in Subtopic 350-40 to prescriptive and sequential software development phases (or “project stages”), and requires an entity to start capitalizing software costs when both (1) management has authorized and committed to funding the software project and (2) it is probable that the project will be completed and the software will be used to perform the function intended. The ASU may be applied using either a prospective, retrospective, or modified transition approach, and is effective for annual reporting periods beginning after December 15, 2027 and interim reporting periods within such annual reporting periods (January 1, 2028 for Kodak). Kodak is currently evaluating the impact of this ASU.
In December 2025, the FASB issued ASU 2025-10, Government Grants (Topic 832). ASU 2025-10 establishes authoritative guidance on the accounting for government grants received by business entities, as GAAP previously did not provide specific authoritative guidance about the recognition, measurement and presentation of government grants. This ASU may be applied using either a retrospective, modified retrospective, or modified prospective approach, and is effective for annual reporting periods beginning after December 15, 2028 and interim reporting periods within such annual reporting periods (January 1, 2029 for Kodak). Kodak is currently evaluating the impact of this ASU.
In April 2026, the FASB issued ASU 2026-01, Equity (Topic 505): Initial Measurement of Paid-in-Kind Dividends on Equity-Classified Preferred Stock. ASU 2026-01 requires that such dividends be initially measured on the basis of the dividend rate stated in the preferred stock agreement. The ASU may be applied on either a prospective or modified retrospective basis, and is effective for annual reporting periods beginning after December 15, 2026 and interim reporting periods within those annual reporting periods (January 1, 2027 for Kodak). Kodak is currently evaluating the impact of this ASU.
7
NOTE 2: CASH, CASH EQUIVALENTS AND RESTRICTED CASH
The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the Consolidated Statement of Financial Position that sums to the total of such amounts shown in the Consolidated Statement of Cash Flows:
|
|
March 31, |
|
|
December 31, |
|
||
(in millions) |
|
2026 |
|
|
2025 |
|
||
Cash and cash equivalents |
|
$ |
|
|
$ |
|
||
Restricted cash reported in Other current assets |
|
|
|
|
|
|
||
Restricted cash |
|
|
|
|
|
|
||
Total cash, cash equivalents and restricted cash shown in the Consolidated Statement |
|
$ |
|
|
$ |
|
||
Restricted cash reported in Other current assets on the Consolidated Statement of Financial Position primarily represented amounts that support hedging activities as of March 31, 2026 and December 31, 2025.
Restricted cash included $
NOTE 3: INVENTORIES, NET
|
|
March 31, |
|
|
December 31, |
|
||
(in millions) |
|
2026 |
|
|
2025 |
|
||
Finished goods |
|
$ |
|
|
$ |
|
||
Work in process |
|
|
|
|
|
|
||
Raw materials |
|
|
|
|
|
|
||
Total |
|
$ |
|
|
$ |
|
||
NOTE 4: OTHER CURRENT ASSETS
|
|
March 31, |
|
|
December 31, |
|
||
(in millions) |
|
2026 |
|
|
2025 |
|
||
Short-term investments (1) |
|
$ |
|
|
$ |
|
||
Restricted cash |
|
|
|
|
|
|
||
Contract assets |
|
|
|
|
|
|
||
Estimated workers' compensation recoveries |
|
|
|
|
|
|
||
Other |
|
|
|
|
|
|
||
Total |
|
$ |
|
|
$ |
|
||
The Other component above consists of other miscellaneous current assets that, individually, were less than
8
NOTE 5: OTHER LONG-TERM LIABILITIES
|
|
March 31, |
|
|
December 31, |
|
||
(in millions) |
|
2026 |
|
|
2025 |
|
||
Workers' compensation |
|
$ |
|
|
$ |
|
||
Asset retirement obligations |
|
|
|
|
|
|
||
Deferred taxes |
|
|
|
|
|
|
||
Deferred brand licensing revenue |
|
|
|
|
|
|
||
Environmental liabilities |
|
|
|
|
|
|
||
Embedded preferred stock derivative liability (1) |
|
|
|
|
|
— |
|
|
Other |
|
|
|
|
|
|
||
Total |
|
$ |
|
|
$ |
|
||
The Other component above consists of other miscellaneous long-term liabilities that, individually, were less than
NOTE 6: DEBT AND CREDIT FACILITIES
Term Loan Credit Agreement
On March 11, 2026, in connection with the Series B Preferred Stock Amendment (refer to Note 7, “Redeemable, Convertible Preferred Stock” for additional details on the Series B Preferred Stock Amendment), the Company and certain of its subsidiaries entered into the Fourth Amendment to the term loan credit agreement (the “Term Loan Amendment”), which amends the Company’s Amended and Restated Credit Agreement, dated as of June 30, 2023 (as amended, the “Term Loan Credit Agreement”) between the Company, certain of its subsidiaries, the lenders party thereto, and Alter Domus (US) LLC, as administrative agent. Under the Term Loan Credit Agreement, the term loan lenders provided the Company with a commitment to provide term loans in an aggregate principal amount of $
The Term Loan Amendment required the Company to prepay an aggregate $
On March 13, 2026, the Company paid $
NOTE 7: REDEEMABLE, CONVERTIBLE PREFERRED STOCK
Redeemable convertible preferred stock was as follows:
|
|
March 31, |
|
|
December 31, |
|
||
(in millions) |
|
2026 |
|
|
2025 |
|
||
|
$ |
|
|
$ |
|
|||
|
$ |
|
|
$ |
|
|||
9
4.0% Series B Preferred Stock
On February 25, 2021, the Company filed with the Department of Treasury of the State of New Jersey a Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation of the Company (the “Series B Certificate of Designations”) which established the designation, number of shares, rights, preferences and limitations of the Company’s
On February 26, 2021, the Company agreed to exchange one million shares of Series A Preferred Stock held by Southeastern Asset Management, Inc. (“Southeastern”) and Longleaf Partners Small-Cap Fund, C2W Partners Master Fund Limited and Deseret Mutual Pension Trust, which were investment funds managed by Southeastern at the time (such investment funds, collectively, the “Purchasers”), for shares of the Company’s
Embedded Conversion Features
Kodak allocated $
Dividend and Other Rights
Holders of
Series B Preferred Stock Purchase
On December 5, 2025, certain funds affiliated with Kennedy Lewis (such funds, collectively, the “KL Funds”) purchased all outstanding shares of the
Extinguishment of 4.0% Series B Preferred Stock
On March 11, 2026 (the “Amendment Date”), the Company filed with the Department of Treasury of the State of New Jersey a Certificate of Amendment to the Series B Certificate of Designations which amended certain terms of the Company’s
The Company evaluated the amendment to the Series B Preferred Stock and determined that the
6.0% Series B Preferred Stock
The total fair value of the
10
Dividend and Other Rights
The
Redemption Features
If any shares of
Conversion Features
Each share of
The Company has the right, subject to certain conditions, to cause the mandatory conversion of the
Upon a voluntary or mandatory conversion of the
Embedded Conversion Features
The Company concluded the economic characteristics and risks of the embedded conversion features are not considered clearly and closely related to the
The fair value of the embedded derivative as of March 31, 2026 was a liability of $
11
Beneficial Ownership Side Letter
On March 11, 2026, in connection with the Series B Preferred Stock Amendment, the Company entered into an amendment to an existing agreement (the “Side Letter”) with Kennedy Lewis Management LP and Kennedy Lewis Capital Partners Master Fund III LP, KLIM Delta HQC3 LP, Kennedy Lewis (EU) SPV LP and KLCP Co-Investment Opportunities III LP, (each, a “Fund”) which provides that no Fund shall have the right to convert any shares of
Investor Rights Agreement
On March 11, 2026, in connection with the Series B Preferred Stock Amendment, the Company entered into an Investor Rights Agreement (the “Series B Investor Rights Agreement”) with Kennedy Lewis Investment Management LLC (together with its affiliates and certain funds, accounts or clients managed, advised or sub-advised by Kennedy Lewis Investment Management LLC or its affiliates, “Kennedy Lewis”). Under the terms of the Series B Investor Rights Agreement, Kennedy Lewis is entitled to certain preemptive rights in connection with future issuances of the Company’s equity securities and the Company is entitled to rights of first refusal in connection with any proposed transfer by Kennedy Lewis of the Series B Preferred Stock, in each case, subject to customary terms and conditions. In addition, the Company has agreed to provide Kennedy Lewis with a reasonable opportunity to participate in future debt financings.
Registration Rights Agreement:
On March 11, 2026, in connection with the Series B Preferred Stock Amendment, the Company entered into a Registration Rights Agreement (the “Series B Registration Rights Agreement”) with Kennedy Lewis. Under the terms of the Series B Registration Rights Agreement, Kennedy Lewis (i) is entitled to require the Company to register for resale the shares of Common Stock issuable upon conversion of the Series B Preferred Stock, along with other shares of Common Stock held by Kennedy Lewis, on a shelf registration statement and (ii) has certain demand rights with respect to takedowns from such shelf registration statement. The Series B Registration Rights Agreement includes customary terms and conditions, including certain customary indemnification obligations.
NOTE 8: LEASES
Income recognized on operating lease arrangements for the three months ended March 31, 2026 and 2025 is presented below. Income recognized for sales-type lease arrangements for the three months ended March 31, 2026 and 2025 was $
|
|
Three Months Ended |
|
|||||
|
|
March 31, |
|
|||||
(in millions) |
|
2026 |
|
|
2025 |
|
||
Lease income - operating leases: |
|
|
|
|
|
|
||
Lease income |
|
$ |
|
|
$ |
|
||
Variable lease income |
|
|
|
|
|
|
||
Total lease income |
|
$ |
|
|
$ |
|
||
NOTE 9: COMMITMENTS AND CONTINGENCIES
As of March 31, 2026, the Company had outstanding letters of credit of $
12
Kodak’s Brazilian operations are involved in various litigation matters in Brazil and have received or been the subject of numerous governmental assessments related to indirect and other taxes in various stages of litigation, as well as civil litigation and disputes associated with former employees and contract labor. The tax matters, which comprise the majority of the litigation matters, are primarily related to federal and state value-added taxes and income taxes. Kodak’s Brazilian operations are disputing these matters and intend to vigorously defend its position. Kodak routinely assesses all these matters as to the probability of ultimately incurring a liability in its Brazilian operations and records its best estimate of the ultimate loss in situations where it assesses the likelihood of loss as probable. As of March 31, 2026, Kodak’s Brazilian operations maintained accruals of approximately $
In connection with assessments in Brazil, local regulations may require Kodak’s Brazilian operations to post security for a portion of the amounts in dispute. As of March 31, 2026, Kodak’s Brazilian operations have posted security composed of $
In addition, Kodak is involved in various lawsuits, claims, investigations, remediations and proceedings, including, from time to time, commercial, customs, employment, environmental, tort and health and safety matters, which are being handled and defended in the ordinary course of business. Kodak is also subject, from time to time, to various assertions, claims, proceedings and requests for indemnification concerning intellectual property, including patent infringement suits involving technologies that are incorporated in a broad spectrum of Kodak’s products such as the on-going patent infringement claims brought by FUJIFILM Corporation against Eastman Kodak Company (in the US) and its German subsidiaries (in Germany) alleging that certain of Kodak’s SONORA process free plates infringe four of its patents in each jurisdiction. These matters are in various stages of investigation and litigation and are being vigorously defended. Based on information currently available, Kodak does not believe that it is probable that the outcomes in these various matters, individually or collectively, will have a material adverse effect on its financial condition or results of operations. Litigation is inherently unpredictable, and judgments could be rendered or settlements entered that could adversely affect Kodak’s operating results or cash flows in a particular period. Kodak routinely assesses all of its litigation and threatened litigation as to the probability of ultimately incurring a liability and records its best estimate of the ultimate loss in situations where it assesses the likelihood of loss as probable.
NOTE 10: GUARANTEES
In accordance with the terms of a settlement agreement concerning certain of the Company’s historical environmental liabilities at Eastman Business Park, a more than
Extended Warranty Arrangements
Kodak offers its customers extended warranty arrangements that are generally
(in millions) |
|
|
|
|
Deferred revenue on extended warranties as of December 31, 2025 |
|
$ |
|
|
New extended warranty and maintenance arrangements deferred |
|
|
|
|
Recognition of extended warranty and maintenance arrangement revenue |
|
|
( |
) |
Deferred revenue on extended warranties as of March 31, 2026 |
|
$ |
|
|
13
NOTE 11: REVENUE
Disaggregation of Revenue
The following tables present revenue disaggregated by major product and geography:
Major Product:
Three Months Ended |
|
|||||||||||||||||||
March 31, 2026 |
|
|||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
Advanced |
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
Materials |
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
and |
|
|
|
|
|
|
|
|
|
|
|||||
(in millions) |
|
|
|
Chemicals |
|
|
Brand |
|
|
All Other |
|
|
Total |
|
||||||
Core products and services (1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Plates, inks and other consumables |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|||||
Ongoing service arrangements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Total annuities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Equipment & software |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Film and chemicals |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Total core products and services |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Growth products (2) |
|
|
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
|
|||
Other (3) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Total |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|||||
Three Months Ended |
|
|||||||||||||||||||
March 31, 2025 |
|
|||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
Advanced |
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
Materials |
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
and |
|
|
|
|
|
|
|
|
|
|
|||||
(in millions) |
|
|
|
Chemicals |
|
|
Brand |
|
|
All Other |
|
|
Total |
|
||||||
Core products and services (1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Plates, inks and other consumables |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|||||
Ongoing service arrangements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Total annuities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Equipment & software |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Film and chemicals |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Total core products and services |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Growth products (2) |
|
|
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
|
|||
Other (3) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Total |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|||||
14
Geography (1):
Three Months Ended |
|
|||||||||||||||||||
March 31, 2026 |
|
|||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
Advanced |
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
Materials |
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
and |
|
|
|
|
|
|
|
|
|
|
|||||
(in millions) |
|
|
|
Chemicals |
|
|
Brand |
|
|
All Other |
|
|
Total |
|
||||||
United States |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|||||
Canada |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
North America |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Europe, Middle East and Africa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Asia Pacific |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Latin America |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Total |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|||||
Three Months Ended |
|
|||||||||||||||||||
March 31, 2025 |
|
|||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
Advanced |
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
Materials |
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
and |
|
|
|
|
|
|
|
|
|
|
|||||
(in millions) |
|
|
|
Chemicals |
|
|
Brand |
|
|
All Other |
|
|
Total |
|
||||||
United States |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|||||
Canada |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
North America |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Europe, Middle East and Africa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Asia Pacific |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Latin America |
|
|
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
|
|||
Total |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|||||
Contract Balances
The timing of revenue recognition, billings and cash collections results in billed trade receivables, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) in the Consolidated Statement of Financial Position. The contract assets are transferred to trade receivables when the rights to consideration become unconditional. The amounts recorded for contract assets at both March 31, 2026 and December 31, 2025 was $
Revenue recognized for the three months ended March 31, 2026 and 2025 that was included in the contract liability balance at the beginning of the respective fiscal years was $
Kodak does not disclose the value of unsatisfied performance obligations for contracts with an original expected length of one year or less or for which revenue is recognized at the amount to which Kodak has the right to invoice for services performed.
15
Performance obligations with an original expected length of greater than
NOTE 12: OTHER CHARGES, NET
|
|
Three Months Ended |
|
|||||
|
|
March 31, |
|
|||||
(in millions) |
|
2026 |
|
|
2025 |
|
||
Interest income |
|
$ |
( |
) |
|
$ |
( |
) |
Loss on foreign exchange transactions |
|
|
|
|
|
|
||
Change in fair value of embedded preferred stock derivative liability (1) |
|
|
|
|
|
|
||
Other |
|
|
( |
) |
|
|
|
|
Total |
|
$ |
|
|
$ |
|
||
NOTE 13: INCOME TAXES
Kodak’s income tax provision and effective tax rate were as follows:
|
|
Three Months Ended |
|
|||||
|
|
March 31, |
|
|||||
(dollars in millions) |
|
2026 |
|
|
2025 |
|
||
Loss from operations before income taxes |
|
$ |
( |
) |
|
$ |
( |
) |
Effective tax rate |
|
|
( |
)% |
|
|
( |
)% |
Provision for income taxes |
|
|
|
|
|
|
||
Benefit for income taxes at U.S. statutory tax rate |
|
|
( |
) |
|
|
( |
) |
Difference between tax at effective vs. statutory rate |
|
$ |
|
|
$ |
|
||
For the three months ended March 31, 2026, the difference between Kodak’s effective tax rate and the U.S. statutory rate of
For the three months ended March 31, 2025, the difference between Kodak’s effective tax rate and the U.S. statutory rate of
In December 2021, the Organisation for Economic Cooperation and Development (“OECD”) introduced Base Erosion and Profit Shifting (“BEPS”) Pillar 2 rules that impose a global minimum tax rate of 15%. Many participating countries enacted changes which took effect in 2024. After considering the applicable tax law changes in the Pillar 2 implementation, Kodak determined there was no material impact to its tax provision for the three months ended March 31, 2026 and 2025.
In March 2026, German Federal Fiscal Court (BFH) ruling (I R 37/22) confirmed that profit and loss transfer agreements ("PLTA") must be actually and timely implemented to maintain a valid tax group in Germany, including timely settlement of profit or loss compensation amongst entities in the group. Kodak is in the process of gathering information and assessing the impacts, if any, on the tax positions of the entities in the Company's German group for the 2021-2025 periods that are impacted by this ruling.
16
NOTE 14: RETIREMENT PLANS
Components of the net periodic benefit cost for all major U.S. and non-U.S. defined benefit pension plans are as follows:
|
|
Three Months Ended |
|
|||||||||||||
|
|
March 31, |
|
|||||||||||||
|
|
2026 |
|
|
2025 |
|
||||||||||
(in millions) |
|
U.S. |
|
|
Non-U.S. |
|
|
U.S. |
|
|
Non-U.S. |
|
||||
Major defined benefit plans: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Service cost |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
||||
Interest cost |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Expected return on plan assets |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Amortization of: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Prior service cost |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Actuarial loss (gain) |
|
|
|
|
|
|
|
|
( |
) |
|
|
|
|||
Net pension (income) expense before special |
|
|
( |
) |
|
|
|
|
|
( |
) |
|
|
|
||
Special termination benefits (1) |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Total net pension (income) expense |
|
$ |
( |
) |
|
$ |
|
|
$ |
( |
) |
|
$ |
|
||
(1)
Restructuring costs and other in the Consolidated Statement of Operations for that period.
On January 21, 2025, the Board of Directors of Kodak approved the termination of the Kodak Retirement Income Plan (“KRIP”), effective March 31, 2025, and no further benefits were accrued under KRIP following this date. In addition, the Board of Directors approved a defined benefit retirement plan (the “Kodak Cash Balance Plan”) as a replacement for KRIP which became effective on March 1, 2025 for new hires and on April 1, 2025 for then current employees. The benefits under the Kodak Cash Balance Plan are substantially the same as those under the cash balance feature of KRIP. On November 26, 2025, all pension obligations under KRIP were fully settled and the excess pension assets were reverted to the Company.
17
NOTE 15: EARNINGS PER SHARE
Basic earnings per share are calculated using the weighted-average number of shares of Common Stock outstanding during the period. Diluted earnings per share calculations include any dilutive effect of potential common shares. In periods with a net loss available to common shareholders, diluted earnings per share are calculated using weighted-average basic shares for that period, as utilizing diluted shares would be anti-dilutive to loss per share.
A reconciliation of the amounts used to calculate basic and diluted loss per share for the three months ended March 31, 2026 and 2025 follows:
|
|
Three Months Ended |
|
|||||
|
|
March 31, |
|
|||||
(in millions) |
|
2026 |
|
|
2025 |
|
||
Net loss |
|
$ |
( |
) |
|
$ |
( |
) |
Less: Series B Preferred stock cash dividends |
|
|
( |
) |
|
|
( |
) |
Less: Series C Preferred stock in-kind dividends |
|
|
— |
|
|
|
( |
) |
Less: Preferred stock deemed dividends |
|
|
( |
) |
|
|
— |
|
Less: Deemed dividend on preferred stock amendment |
|
|
( |
) |
|
|
— |
|
Net loss available to common shareholders - basic |
|
$ |
( |
) |
|
$ |
( |
) |
|
|
Three Months Ended |
|
|||||
|
|
March 31, |
|
|||||
(in millions of shares) |
|
2026 |
|
|
2025 |
|
||
Weighted average shares — basic |
|
|
|
|
|
|
||
Effect of dilutive securities |
|
|
|
|
|
|
||
Unvested restricted stock units |
|
|
— |
|
|
|
— |
|
Employee stock options |
|
|
— |
|
|
|
— |
|
Series B Preferred Stock |
|
|
— |
|
|
|
— |
|
Weighted average shares — diluted |
|
|
|
|
|
|
||
As a result of the net loss available to common shareholders for the three months ended March 31, 2026, Kodak calculated diluted earnings per share using weighted-average basic shares outstanding. If Kodak had reported earnings available to common shareholders for the three months ended March 31, 2026, the calculation of diluted earnings per share would have included the assumed vesting of
As a result of the net loss available to common shareholders for the three months ended March 31, 2025, Kodak calculated diluted earnings per share using weighted-average basic shares outstanding. If Kodak had reported earnings available to common shareholders for the three months ended March 31, 2025, the calculation of diluted earnings per share would have included the assumed vesting of
The computation of diluted earnings per share for the three months ended March 31, 2026 excluded the impact of (1) the assumed conversion of
The computation of diluted earnings per share for the three months ended March 31, 2025 excluded the impact of (1) the assumed conversion of
18
NOTE 16: SHAREHOLDERS’ EQUITY
The Company has
Common Stock
As of March 31, 2026 and December 31, 2025, there were
Preferred Stock
Series B Preferred stock issued and outstanding included
Treasury Stock
Treasury stock consisted of approximately
NOTE 17: OTHER COMPREHENSIVE INCOME (LOSS)
The changes in Other comprehensive income (loss) by component were as follows:
|
|
Three Months Ended |
|
|||||
|
|
March 31, |
|
|||||
(in millions) |
|
2026 |
|
|
2025 |
|
||
Currency translation adjustments |
|
|
|
|
|
|
||
Currency translation adjustments |
|
$ |
|
|
$ |
|
||
|
|
|
|
|
|
|
||
Pension and other postretirement benefit plan changes |
|
|
|
|
|
|
||
Newly established net actuarial loss |
|
|
|
|
|
( |
) |
|
Tax provision |
|
|
|
|
|
|
||
Newly established net actuarial loss, net of tax |
|
|
|
|
|
( |
) |
|
Reclassification adjustments: |
|
|
|
|
|
|
||
Amortization of prior service cost (1) |
|
|
|
|
|
|
||
Amortization of actuarial gains (1) |
|
|
|
|
|
( |
) |
|
Total reclassification adjustments |
|
|
|
|
|
( |
) |
|
Tax provision |
|
|
|
|
|
|
||
Reclassification adjustments, net of tax |
|
|
|
|
|
( |
) |
|
Pension and other postretirement benefit plan changes, net of tax |
|
|
|
|
|
( |
) |
|
Other comprehensive income (loss) |
|
$ |
|
|
$ |
( |
) |
|
19
NOTE 18: SEGMENT INFORMATION
Kodak has
Print: The Print segment is comprised of
Advanced Materials and Chemicals: The Advanced Materials and Chemicals segment is comprised of
Brand: The Brand segment contains the brand licensing business.
The balance of Kodak’s continuing operations, which primarily represent the operations of Eastman Business Park ("EBP") and do not meet the criteria of a reportable segment, are reported in All Other revenues and All Other Operational EBITDA.
The accounting policies of the segments are the same as those described in the summary of significant accounting policies in Note 1 included in the 2025 Form 10-K. There are no intersegment sales between the segments.
The CODM uses Operational EBITDA in assessing segment performance and deciding how to allocate resources for each segment predominantly through the annual budget and forecasting process. The CODM evaluates Operational EBITDA budget-to-actual variances and changes in Operational EBITDA from prior periods when comparing the results of each segment with one another.
Segment financial information is shown below. Asset information by reportable segment is not disclosed below as this information is not regularly provided to or used by the CODM in assessing performance and allocating resources.
20
Segment Revenues, Operational EBITDA and Consolidated Loss from Continuing Operations Before Income Taxes
|
Three Months Ended |
|
|||||
|
March 31, |
|
|||||
|
2026 |
|
|
2025 |
|
||
(in millions) |
|
|
|
|
|
||
Print: |
|
|
|
|
|
||
Revenues from external customers |
$ |
|
|
$ |
|
||
Cost of revenues |
|
|
|
|
|
||
Selling, general and administrative expenses |
|
|
|
|
|
||
Research and development expenses |
|
|
|
|
|
||
Operational EBITDA |
|
|
|
|
( |
) |
|
|
|
|
|
|
|
||
Advanced Materials and Chemicals: |
|
|
|
|
|
||
Revenues from external customers |
|
|
|
|
|
||
Cost of revenues |
|
|
|
|
|
||
Selling, general and administrative expenses |
|
|
|
|
|
||
Research and development expenses |
|
|
|
|
|
||
Operational EBITDA |
|
|
|
|
|
||
|
|
|
|
|
|
||
Brand: |
|
|
|
|
|
||
Revenues from external customers |
|
|
|
|
|
||
Selling, general and administrative expenses |
|
|
|
|
|
||
Operational EBITDA |
|
|
|
|
|
||
|
|
|
|
|
|
||
Total Operational EBITDA for Reportable Segments |
|
|
|
|
|
||
All Other Operational EBITDA |
|
( |
) |
|
|
|
|
Depreciation and amortization |
|
( |
) |
|
|
( |
) |
Restructuring costs and other |
|
|
|
|
( |
) |
|
Stock-based compensation |
|
( |
) |
|
|
( |
) |
Consulting and other costs (1) |
|
|
|
|
|
||
Idle costs (2) |
|
( |
) |
|
|
( |
) |
Other operating expense, net (3) |
|
( |
) |
|
|
|
|
Interest expense (3) |
|
( |
) |
|
|
( |
) |
Pension income excluding service cost component (3) |
|
|
|
|
|
||
Loss on early extinguishment of debt (3) |
|
( |
) |
|
|
|
|
Other charges, net (3) |
|
( |
) |
|
|
|
|
Consolidated loss from continuing operations before income taxes |
$ |
( |
) |
|
$ |
( |
) |
litigation. Consulting and other costs included $
21
A reconciliation of reportable segment revenues to consolidated revenues follows:
|
Three Months Ended |
|
|||||
|
March 31, |
|
|||||
(in millions) |
2026 |
|
|
2025 |
|
||
Total Reportable Segment Revenues |
$ |
|
|
$ |
|
||
All Other Revenues |
|
|
|
|
|
||
Total Consolidated Revenues |
$ |
|
|
$ |
|
||
There was
Amortization and depreciation expense by segment are not included in the segment measure of profit and loss but are regularly provided to the CODM.
|
Three Months Ended |
|
|||||
(in millions) |
March 31, |
|
|||||
Intangible asset amortization expense from continuing operations: |
2026 |
|
|
2025 |
|
||
$ |
|
|
$ |
|
|||
Total |
$ |
|
|
$ |
|
||
|
Three Months Ended |
|
|||||
(in millions) |
March 31, |
|
|||||
Depreciation expense from continuing operations: |
2026 |
|
|
2025 |
|
||
$ |
|
|
$ |
|
|||
Advanced Materials and Chemicals |
|
|
|
|
|
||
Total |
$ |
|
|
$ |
|
||
(in millions) |
March 31, |
|
|
December 31, |
|
||
Long-lived assets located in: (1) |
2026 |
|
|
2025 |
|
||
The United States |
$ |
|
|
$ |
|
||
Europe, Middle East and Africa |
|
|
|
|
|
||
Asia Pacific |
|
|
|
|
|
||
Canada and Latin America |
|
|
|
|
|
||
Non-U.S. countries total (2) |
|
|
|
|
|
||
Total |
$ |
|
|
$ |
|
||
(1)
(2)
non-U.S. property, plant and equipment as of December 31, 2025, $
NOTE 19: FINANCIAL INSTRUMENTS
Kodak, as a result of its global operating and financing activities, is exposed to changes in foreign currency exchange rates, commodity pricing and interest rates, which may adversely affect its results of operations and financial position. Kodak manages such exposures, in part, with derivative financial instruments. Foreign currency forward contracts are used to mitigate currency risk related to foreign currency denominated assets and liabilities, as well as forecasted foreign currency denominated intercompany assets.
22
Kodak’s exposure to changes in interest rates results from its investing and borrowing activities used to meet its liquidity needs. Kodak does not utilize financial instruments for trading or other speculative purposes.
Kodak’s foreign currency forward contracts are not designated as hedges and are marked to market through net loss at the same time that the exposed assets and liabilities are re-measured through net loss (both in Other charges, net in the Consolidated Statement of Operations). The notional amount of such contracts open at March 31, 2026 and December 31, 2025 was approximately $
The net effect of foreign currency forward contracts in the results of operations is shown in the following table:
|
|
Three Months Ended |
|
|||||
|
|
March 31, |
|
|||||
(in millions) |
|
2026 |
|
|
2025 |
|
||
Net loss (gain) from derivatives not designated as hedging instruments |
|
$ |
|
|
$ |
( |
) |
|
Kodak had
In the event of a default under any of the Company’s credit agreements, or a default under any derivative contract or similar obligation of Kodak, subject to certain minimum thresholds, the derivative counterparties would have the right, although not the obligation, to require immediate settlement of some or all open derivative contracts at their then-current fair value, but with liability positions netted against asset positions with the same counterparty.
Fair Value
Fair values of Kodak’s foreign currency forward contracts are determined using observable inputs (Level 2 fair value measurements) and are based on the present value of expected future cash flows (an income approach valuation technique) considering the risks involved and using discount rates appropriate for the duration of the contracts. The gross fair value of foreign currency forward contracts in an asset position are reported in Other current assets and the gross fair value of foreign currency forward contracts in a liability position are reported in Other current liabilities in the Consolidated Statement of Financial Position. The gross fair value of forward contracts in an asset position as of March 31, 2026 and December 31, 2025 was
The fair values of long-term debt (Level 2 fair value measurements) are determined by reference to quoted market prices of similar instruments, if available, or by pricing models based on the value of related cash flows discounted at current market interest rates. The fair values of long-term borrowings were $
The carrying values of cash and cash equivalents, restricted cash and the current portion of long-term debt approximate their fair values at both March 31, 2026 and December 31, 2025.
Transfers between levels of the fair value hierarchy are recognized based on the actual date of the event or change in circumstances that caused the transfer. There were no transfers between levels of the fair value hierarchy during the three months ended March 31, 2026.
As disclosed in Note 7, “Redeemable, Convertible Preferred Stock”, the embedded conversion options were bifurcated from the
23
The following table presents the key inputs used in the determination of fair value for the embedded conversion options:
|
|
Valuation Date |
|
|||||
|
|
March 31, |
|
|
March 11, |
|
||
|
|
2026 |
|
|
2026 |
|
||
Total value of embedded derivative ($ millions) |
|
$ |
|
|
$ |
|
||
Kodak's closing stock price |
|
$ |
|
|
$ |
|
||
Expected stock price volatility |
|
|
% |
|
|
% |
||
Risk free rate |
|
|
% |
|
|
% |
||
Implied yield on preferred stock |
|
|
% |
|
|
% |
||
24
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
CAUTIONARY STATEMENT PURSUANT TO SAFE HARBOR PROVISIONS OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995
This report on Form 10-Q includes “forward–looking statements” as that term is defined under the Private Securities Litigation Reform Act of 1995.
Forward–looking statements include statements concerning Kodak’s plans, objectives, goals, strategies, future events, future revenue or performance, capital expenditures, liquidity, investments, financing needs and business trends and other information that is not historical information. When used in this document, the words “estimates,” “expects,” “anticipates,” “projects,” “plans,” “intends,” “believes,” “predicts,” “forecasts,” “strategy,” “continues,” “goals,” “targets” or future or conditional verbs, such as “will,” “should,” “could,” or “may,” and similar words and expressions, as well as statements that do not relate strictly to historical or current facts, are intended to identify forward–looking statements. All forward–looking statements, including management’s examination of historical operating trends and data, are based upon Kodak’s current expectations and assumptions. Forward-looking statements are subject to risks, uncertainties and other factors that could cause actual results or outcomes, or timing of actual results or outcomes, to differ materially from historical results or those expressed in or implied by such forward-looking statements. Important factors that could cause actual events, results or outcomes, or their timing, to differ materially from the forward-looking statements include, among others, the risks and uncertainties described in more detail in the Company’s Annual Report on Form 10‑K for the year ended December 31, 2025 (“2025 Form 10-K”) under the headings “Business,” “Risk Factors,” “Legal Proceedings,” and/or “Management’s Discussion and Analysis of Financial Condition and Results of Operations–Liquidity and Capital Resources,” in the corresponding sections of this report on Form 10‑Q and in other filings the Company makes with the SEC from time to time, as well as the following:
25
Future events and other factors may cause Kodak’s actual results or outcomes to differ materially from the forward–looking statements. All forward–looking statements attributable to Kodak or persons acting on its behalf apply only as of the date of this report on Form 10‑Q and are expressly qualified in their entirety by the cautionary statements included or referenced in this document. Kodak undertakes no obligation to update or revise forward–looking statements to reflect events or circumstances that arise after the date made or to reflect the occurrence of unanticipated events, except as required by law.
EXECUTIVE OVERVIEW
Kodak is a global manufacturer focused on commercial print and advanced materials and chemicals. With 79,000 patents earned over 130 years of research and development ("R&D"), Kodak believes in the power of technology and science to enhance what the world sees and creates. Kodak’s innovative, award-winning products, combined with its customer-first approach, make Kodak the partner of choice for commercial printers worldwide. Kodak is committed to environmental stewardship, including industry leadership in developing sustainable solutions for print.
Consolidated revenues in the three months ended March 31, 2026 were $265 million, an increase of $18 million (7%) when compared to the three months ended March 31, 2025. Currency fluctuations had a favorable impact on revenues ($7 million) in the three months ended March 31, 2026 compared to the three months ended March 31, 2025.
Print revenues in the three months ended March 31, 2026 were $180 million, an increase of $15 million (9%) compared to the prior year quarter. Print revenues accounted for 68% of Kodak’s total revenues for the three months ended March 31, 2026. Advanced Materials and Chemicals revenues in the three months ended March 31, 2026 were $76 million, an increase of $2 million (3%) compared to the prior year quarter.
Economic Environment and Other Global Events:
Kodak sells and services its products globally, with more than half of sales generated outside the U.S. The macroeconomic environment remains highly volatile due to changes in trade policies, including tariffs or other trade restrictions or the threat of such actions, geopolitical conflicts, fluctuations in commodity prices, elevated inflation and on-going supply chain constraints, all of which have impacted Kodak’s operations.
These conditions have contributed to increased manufacturing costs, primarily due to the impact of U.S. tariffs on imported goods (including aluminum, steel and certain raw materials and component parts used in Kodak’s manufacturing and supply chain), as well as increases in commodity prices including aluminum and silver, higher labor, material, and distribution costs, and lower production volumes. The Company has implemented various pricing actions, productivity improvements, supply chain and workforce optimization initiatives and other cost savings activities. In addition, the Company has renegotiated supplier contracts and obtained certain tariff exemptions. Collectively, these actions have largely mitigated the impact of higher manufacturing costs and, as a result, did not have a material adverse effect on Kodak’s operations, financial condition or cash flows for the quarter ended March 31, 2026.
Kodak continues to actively monitor the developments related to tariffs to assess additional actions that may be taken to mitigate the effects of future tariff changes, including further pricing actions, additional cost reduction measures, securing alternative suppliers and evaluating potential changes to the Company’s manufacturing footprint. However, there is substantial uncertainty about the duration of existing tariffs or pauses in tariffs, tariff levels and whether additional tariffs or other retaliatory actions may be imposed, modified or suspended. Countries subject to such tariffs have imposed or may in the future impose reciprocal or retaliatory tariffs and other trade measures. These actions and the related rising political tensions could negatively impact global macroeconomic conditions and the stability of global financial markets. The ultimate impact of any tariffs is uncertain and will depend on various factors, including whether the tariffs are maintained and/or implemented, the duration of the tariffs, any exceptions or exemptions that are or may become available and the timing of their implementation, and scope, all of which could have a material adverse effect on Kodak’s business, financial condition and results of operations.
26
As a result of a trade case brought by the Company in the U.S., the following duties are currently being imposed on U.S. imports of aluminum lithographic printing plates: (i) anti-dumping duties of 115.84% on plates manufactured in China by Fujifilm and 317.43% on such plates manufactured in China by other entities, (ii) countervailing duties of 35.66% on practically all plates manufactured in China, and (iii) anti-dumping duties of 91.83% on practically all plates manufactured in Japan. Fujifilm has appealed the basis for the imposition of these duties. These duties are in addition to other tariffs that may be imposed on imports generally, including on aluminum derivative products to the extent applicable. There can be no assurance that the duties imposed on imported plates will provide Kodak effective relief and will not be reduced or impaired by any appeal or other challenge.
Kodak has implemented numerous measures to mitigate the challenges associated with supply chain disruptions and shortages in materials, including increasing safety stock on certain materials, increasing lead-times, providing suppliers with longer forecasts of future demand and certifying additional sources or substitute materials where possible. These measures have enabled Kodak to largely meet current demand.
The Advanced Materials and Chemicals segment has experienced labor shortages in certain manufacturing areas. Increased demand for consumer film products along with manufacturing equipment limitations and labor shortages have contributed to increased backorders. The Advanced Materials and Chemicals segment has increased headcount and made capital investments in equipment upgrades and new equipment that increased capacity and streamlined processes which has reduced backorders and improved operational efficiency. Increased demand for film products may continue to place stress on manufacturing equipment and the labor force without further investment or additional hiring in key areas.
The ongoing changes in global economic conditions and the impact of other global events on Kodak’s operations and financial performance remains uncertain. A further deterioration in economic conditions, sustained supply chain disruptions or constraints in securing raw materials and components, or additional increases in manufacturing and other costs without further pricing actions, productivity improvements, supply chain mitigation actions or other cost saving measures, could unfavorably impact Kodak's operating results.
Kodak’s strategy:
Segments within the print industry and the film industry face competition from digital substitution. Kodak’s strategy is to:
A discussion of opportunities and challenges related to Kodak’s strategy follows:
27
28
RESULTS OF OPERATIONS
2026 COMPARED TO 2025
FIRST QUARTER RESULTS OF OPERATIONS
|
|
Three Months Ended March 31, |
|
|||||||||||||||||
|
|
|
|
|
% of |
|
|
|
|
|
% of |
|
|
|
|
|||||
(dollars in millions) |
|
2026 |
|
|
Sales |
|
|
2025 |
|
|
Sales |
|
|
$ Change |
|
|||||
Revenues |
|
$ |
265 |
|
|
|
|
|
$ |
247 |
|
|
|
|
|
$ |
18 |
|
||
Cost of revenues |
|
|
208 |
|
|
|
|
|
|
201 |
|
|
|
|
|
|
7 |
|
||
Gross profit |
|
|
57 |
|
|
|
22 |
% |
|
|
46 |
|
|
|
19 |
% |
|
|
11 |
|
Selling, general and administrative expenses |
|
|
48 |
|
|
|
18 |
% |
|
|
45 |
|
|
|
18 |
% |
|
|
3 |
|
Research and development costs |
|
|
8 |
|
|
|
3 |
% |
|
|
9 |
|
|
|
4 |
% |
|
|
(1 |
) |
Restructuring costs and other |
|
|
— |
|
|
|
0 |
% |
|
|
5 |
|
|
|
2 |
% |
|
|
(5 |
) |
Other operating expense, net |
|
|
2 |
|
|
|
1 |
% |
|
|
— |
|
|
|
0 |
% |
|
|
2 |
|
Loss from operations before interest expense, pension |
|
|
(1 |
) |
|
|
(0 |
)% |
|
|
(13 |
) |
|
|
(5 |
)% |
|
|
12 |
|
Interest expense |
|
|
6 |
|
|
|
2 |
% |
|
|
14 |
|
|
|
6 |
% |
|
|
(8 |
) |
Pension income excluding service cost component |
|
|
(4 |
) |
|
|
(2 |
)% |
|
|
(22 |
) |
|
|
(9 |
)% |
|
|
18 |
|
Loss on early extinguishment of debt |
|
|
1 |
|
|
|
0 |
% |
|
|
— |
|
|
|
0 |
% |
|
|
1 |
|
Other charges, net |
|
|
9 |
|
|
|
3 |
% |
|
|
— |
|
|
|
0 |
% |
|
|
9 |
|
Loss from operations before income taxes |
|
|
(13 |
) |
|
|
(5 |
)% |
|
|
(5 |
) |
|
|
(2 |
)% |
|
|
(8 |
) |
Provision for income taxes |
|
|
3 |
|
|
|
1 |
% |
|
|
2 |
|
|
|
1 |
% |
|
|
1 |
|
NET LOSS |
|
$ |
(16 |
) |
|
|
(6 |
)% |
|
$ |
(7 |
) |
|
|
(3 |
)% |
|
$ |
(9 |
) |
Revenue
For the three months ended March 31, 2026 revenues increased $18 million compared with the same period in 2025, primarily driven by improved pricing in Print ($10 million) and Advanced Materials and Chemicals ($6 million), favorable foreign currency fluctuations ($7 million) and higher volume in Brand ($1 million), partially offset by lower volume in Advanced Materials and Chemicals ($5 million) and Print ($2 million). See segment discussions for additional details.
Gross Profit
Gross profit for the three months ended March 31, 2026 increased $11 million compared with the same period in 2025, primarily due to improved pricing in Print ($9 million) and Advanced Materials and Chemicals ($5 million), higher margins in Print ($1 million), favorable foreign currency fluctuations ($1 million), reduced manufacturing costs in Print ($1 million), higher volume in Brand ($1 million) and net change in employee benefit reserves ($1 million), partially offset by higher silver costs ($5 million) and manufacturing costs ($2 million) in Advanced Materials and Chemicals, lower volume in Advanced Materials and Chemicals ($1 million) and higher aluminum costs ($1 million). See segment discussions for additional details.
Selling, General and Administrative Expenses
Consolidated selling and general administrative expenses ("SG&A") increased $3 million in the three months ended March 31, 2026 compared to the prior year period, primarily due to an increase in equity compensation costs ($4 million), partially offset by a decline in consulting and other costs ($1 million) related to an insurance reimbursement of legal costs previously paid by the Company associated with investigations and litigation received in the first quarter of 2026 ($1 million).
Research and Development Costs
Consolidated research and development ("R&D") expenses in the three months ended March 31, 2026 were relatively flat compared to the prior year period.
29
Pension Income Excluding Service Cost Component
Pension income excluding service cost component decreased $18 million in the three months ended March 31, 2026 due to lower expected return on assets driven by a decrease in the asset base due to the settlement of the Kodak Retirement Income Plan ("KRIP") in the fourth quarter of 2025. Refer to Note 14, "Retirement Plans".
Other Charges, Net
For details, refer to Note 12, "Other Charges, Net".
REPORTABLE SEGMENTS
Kodak has three reportable segments: Print, Advanced Materials and Chemicals and Brand. A description of Kodak’s reportable segments follows.
Print: The Print segment is comprised of four lines of business: the Prepress Solutions business, the PROSPER business, the Software business and the Electrophotographic Printing Solutions business.
Advanced Materials and Chemicals: The Advanced Materials and Chemicals segment is comprised of five lines of business: the Industrial Film and Chemicals business, the Motion Picture business, the Pharmaceuticals business, the Advanced Materials and Functional Printing business and the IP Licensing and Analytical Services business.
Brand: The Brand segment contains the brand licensing business.
The balance of Kodak’s continuing operations, which primarily represent the operations of EBP and do not meet the criteria of a reportable segment, are reported in All Other revenues and All Other Operational EBITDA.
Segment Revenues
|
|
Three Months Ended |
|
|||||
|
|
March 31, |
|
|||||
(in millions) |
|
2026 |
|
|
2025 |
|
||
|
$ |
180 |
|
|
$ |
165 |
|
|
Advanced Materials and Chemicals |
|
|
76 |
|
|
|
74 |
|
Brand |
|
|
6 |
|
|
|
4 |
|
Total of reportable segments |
|
|
262 |
|
|
|
243 |
|
All Other revenues |
|
|
3 |
|
|
|
4 |
|
Consolidated total |
|
$ |
265 |
|
|
$ |
247 |
|
Kodak’s segment measure of profit and loss is an adjusted earnings before interest, taxes, depreciation and amortization (“Operational EBITDA”). As demonstrated in the table below, Operational EBITDA represents consolidated loss from operations excluding the provision for income taxes; non-service cost components of pension and other postemployment benefits (“OPEB”) income; depreciation and amortization expense; restructuring costs and other; stock-based compensation expense; idle costs; interest expense; loss on early extinguishment of debt; other operating expense, net and other charges, net.
30
Segment Operational EBITDA and Consolidated Loss from Operations Before Income Taxes
|
|
Three Months Ended |
|
|||||
|
|
March 31, |
|
|||||
(in millions) |
|
2026 |
|
|
2025 |
|
||
|
$ |
3 |
|
|
$ |
(9 |
) |
|
Advanced Materials and Chemicals |
|
|
7 |
|
|
|
7 |
|
Brand |
|
|
5 |
|
|
|
4 |
|
All other |
|
|
(2 |
) |
|
|
— |
|
Depreciation and amortization |
|
|
(7 |
) |
|
|
(7 |
) |
Restructuring costs and other |
|
|
— |
|
|
|
(5 |
) |
Stock based compensation |
|
|
(5 |
) |
|
|
(2 |
) |
Consulting and other costs (1) |
|
|
1 |
|
|
|
— |
|
Idle costs (2) |
|
|
(1 |
) |
|
|
(1 |
) |
Other operating expense, net (3) |
|
|
(2 |
) |
|
|
— |
|
Interest expense (3) |
|
|
(6 |
) |
|
|
(14 |
) |
Pension income excluding service cost component (3) |
|
|
4 |
|
|
|
22 |
|
Loss on early extinguishment of debt (3) |
|
|
(1 |
) |
|
|
— |
|
Other charges, net (3) |
|
|
(9 |
) |
|
|
— |
|
Consolidated loss from operations before income taxes |
|
$ |
(13 |
) |
|
$ |
(5 |
) |
(1) Consulting and other costs are professional services and internal costs associated with corporate strategic initiatives and
litigation. Consulting and other costs included $1 million of income in the three months ended March 31, 2026, representing insurance reimbursement of legal costs previously paid by the Company associated with investigations and litigation matters.
(2) Consists of third-party costs such as security, maintenance and utilities required to maintain land and buildings in certain locations
not used in any Kodak operations and the costs, net of any rental income received, of underutilized portions of certain properties.
(3) As reported in the Consolidated Statement of Operations.
There was no change to employee benefit reserves in the three months ended March 31, 2026. Kodak increased employee benefit reserves by approximately $1 million in the three months ended March 31, 2025 due to an increase in workers' compensation reserves driven by changes in discount rates. The increase in reserves in the three months ended March 31, 2025 impacted gross profit by approximately $1 million.
PRINT SEGMENT
|
|
Three Months Ended March 31, |
|
|||||||||
(dollars in millions) |
|
2026 |
|
|
2025 |
|
|
$ Change |
|
|||
Revenues |
|
$ |
180 |
|
|
$ |
165 |
|
|
$ |
15 |
|
|
|
|
|
|
|
|
|
|
|
|||
Operational EBITDA |
|
$ |
3 |
|
|
$ |
(9 |
) |
|
$ |
12 |
|
Operational EBITDA as a % of revenues |
|
|
2 |
% |
|
|
(5 |
)% |
|
|
|
|
Revenues
Print revenues for the three months ended March 31, 2026 increased $15 million primarily due to improved pricing in Prepress Solutions ($10 million), favorable foreign currency fluctuations ($7 million), higher volume in PROSPER ($4 million) and Software ($1 million), partially offset by reduced volume in Prepress Solutions ($4 million) and Electrophotographic Printing Solutions ("EPS") ($3 million).
Operational EBITDA
Print Operational EBITDA for the three months ended March 31, 2026 increased $12 million primarily due to improved pricing in Prepress Solutions ($9 million), higher volume in PROSPER ($1 million) and Software ($1 million), higher margins in EPS ($1 million)
31
and reduced manufacturing costs ($1 million), partially offset by higher costs for aluminum ($1 million) and lower volume in Prepress Solutions ($1 million).
ADVANCED MATERIALS AND CHEMICALS SEGMENT
|
|
Three Months Ended March 31, |
|
|||||||||
(dollars in millions) |
|
2026 |
|
|
2025 |
|
|
$ Change |
|
|||
Revenues |
|
$ |
76 |
|
|
$ |
74 |
|
|
$ |
2 |
|
|
|
|
|
|
|
|
|
|
|
|||
Operational EBITDA |
|
$ |
7 |
|
|
$ |
7 |
|
|
$ |
— |
|
Operational EBITDA as a % of revenues |
|
|
9 |
% |
|
|
9 |
% |
|
|
|
|
Revenues
Advanced Materials and Chemicals revenues for the three months ended March 31, 2026 increased $2 million primarily due to improved pricing in Industrial Film and Chemicals ($6 million), partially offset by a decline in volume ($4 million) in Industrial Film and Chemicals.
Operational EBITDA
Advanced Materials and Chemicals Operational EBITDA was flat for the three months ended March 31, 2026 compared to the prior year period due to improved pricing in Industrial Film and Chemicals ($5 million), favorable foreign currency fluctuations ($1 million) and net change in employee benefit reserves ($1 million), offset by higher silver costs ($5 million) and manufacturing costs ($2 million).
BRAND SEGMENT
|
|
Three Months Ended March 31, |
|
|||||||||
(dollars in millions) |
|
2026 |
|
|
2025 |
|
|
$ Change |
|
|||
Revenues |
|
$ |
6 |
|
|
$ |
4 |
|
|
$ |
2 |
|
|
|
|
|
|
|
|
|
|
|
|||
Operational EBITDA |
|
$ |
5 |
|
|
$ |
4 |
|
|
$ |
1 |
|
Operational EBITDA as a % of revenues |
|
|
83 |
% |
|
|
100 |
% |
|
|
|
|
Revenues
Brand revenues for the three months ended March 31, 2026 increased $2 million due to higher volumes.
Operational EBITDA
Brand Operational EBITDA for the three months ended March 31, 2026 increased $1 million due to higher volumes.
LIQUIDITY AND CAPITAL RESOURCES
Management’s Assessment of Liquidity
Kodak ended the quarter with a cash balance of $299 million, a decrease of $38 million from December 31, 2025.
During the fourth quarter of 2025, the Company completed the settlement of the Kodak Retirement Income Plan ("KRIP") and received $144 million in net cash proceeds from the reversion of KRIP assets, after required debt payments and payment of excise taxes, as well as $158 million of investment assets, of which $9 million was converted to cash in December 2025. The investment assets received by the Company are primarily hedge fund investments which are in redemption.
During the first quarter of 2026, the Company received $46 million of cash from these redemptions. In April 2026, the Company received an additional $39 million of cash and expects to receive $16 million in cash proceeds during the remainder of 2026. The remaining value of the investment assets is expected to be converted to cash primarily in 2027 and 2028.
32
Available liquidity includes existing cash and cash equivalent balances. The amount of available liquidity is subject to fluctuations and includes cash balances held by various entities worldwide. At March 31, 2026 and December 31, 2025 approximately $173 million and $231 million, respectively, of cash and cash equivalents were held within the U.S. and approximately $126 million and $106 million, respectively, of cash and cash equivalents were held outside the U.S. Cash balances held outside the U.S. are generally required to support local country operations and may have high tax costs or other limitations that delay the ability to repatriate, and therefore may not be readily available for transfer to other jurisdictions. Kodak utilizes cash balances outside the U.S. to fund needs in the U.S. through the use of intercompany loans.
As of March 31, 2026 and December 31, 2025, outstanding intercompany loans to the U.S. were $479 million and $509 million, respectively, which included short-term intercompany loans from Kodak’s international finance center of $205 million and $235 million, respectively. In China, where approximately $36 million and $35 million of cash and cash equivalents was held as of March 31, 2026 and December 31, 2025, respectively, there are limitations related to net asset balances that may impact the ability to make cash available to other jurisdictions in the world. Under the terms of the Amended and Restated Term Loan Credit Agreement, the Company is permitted to invest up to $75 million in Restricted Subsidiaries that are not Loan Parties and in joint ventures or Unrestricted Subsidiaries that are not party to the Amended and Restated Term Loan Credit Agreement.
The Company’s Hong Kong subsidiary has an intercompany loan from one of the Company’s Chinese subsidiaries with a maturity date of November 16, 2026, the proceeds of which were in turn loaned to the Company. The terms of the intercompany loan require the Company to make efforts to repay the outstanding loan balance prior to maturity. The outstanding amount of the intercompany loan as of March 31, 2026 was $68 million. The Company is evaluating repayment alternatives for the current loan agreement which would allow Kodak and its subsidiaries to perform their obligations to each other while minimizing the impact on U.S. liquidity taking into account requirements imposed by Chinese regulators. Any amounts repaid to the Chinese subsidiary may not be able to be loaned, repatriated or otherwise moved back to the U.S., in which case the Company’s U.S. liquidity would be reduced.
On March 11, 2026, the Company filed with the Department of Treasury of the State of New Jersey a Certificate of Amendment to the Series B Certificate of Designations which amended certain terms of the Company’s 4.0% Series B Preferred Stock (the “Series B Preferred Stock Amendment”) and set forth the terms of the Company’s 6.0% Series B Convertible Preferred Stock, no par value (the “6.0% Series B Preferred Stock”). The Series B Preferred Stock Amendment (i) extended the mandatory redemption date from May 28, 2026 to June 11, 2029, (ii) increased the annual cash dividend rate from 4.0% to 6.0% and (iii) reduced the conversion price from $10.50 to $10.00 per share and modified certain other conversion terms. The 6.0% Series B Preferred Stock is convertible into shares of common stock; however, the timing and likelihood of such conversion are dependent on market conditions and other factors and is subject to certain restrictions whereby the Company would be required to pay cash in lieu of issuing shares in excess of a maximum number. The cash payment is determined based on the market value of the Company’s common stock as of the applicable conversion date.
On March 11, 2026, in connection with the Series B Preferred Stock Amendment, the Company and certain of its subsidiaries entered into the Fourth Amendment to the term loan credit agreement (the “Term Loan Amendment”), which amends the Company’s Amended and Restated Credit Agreement, dated as of June 30, 2023 (as amended, the “Term Loan Credit Agreement”). Under the Term Loan Credit Agreement, the term loan lenders provided the Company with a commitment to provide term loans in an aggregate principal amount of $450 million (the “Term Loans”). The Term Loan Amendment requires the Company to prepay an aggregate $50 million principal amount of Term Loans on or prior to March 18, 2026 and an additional $50 million principal amount of Term Loans on or prior to June 1, 2026, in each case, plus a prepayment premium equal to one percent. On March 13, 2026, the Company paid $50 million of the outstanding principal amount of the Term Loans, $1 million in accrued uncapitalized interest and a prepayment premium equal to one percent of the principal amount paid. The Company expects to fund the remaining required prepayment through a combination of cash proceeds from the redemption of KRIP investment assets and cash on hand.
Kodak's cash flows continue to be negatively impacted by higher manufacturing, labor, material and distribution costs, along with volume declines, supply chain disruptions and shortages in materials and labor. These impacts have been largely mitigated by price increases, savings relating to rationalization, cost reductions and operational efficiencies and supply chain-related cost improvements. In addition, the cash proceeds from the KRIP reversion and additional cash proceeds expected from the redemption or other monetization of investment assets provides additional liquidity to the Company to adequately fund on‐going operations.
The economic uncertainties surrounding the current inflationary environment and other global events represent additional elements of complexity in Kodak’s plans to return to sustainable positive cash flow. The Company cannot predict the duration and scope of such events, including the impact of rising costs of labor, commodity and distribution costs and increased product costs from tariffs, geopolitical conflicts and other factors such as the Company's ability to continue to secure raw materials and components, the
33
ability to increase prices to offset rising product costs or how quickly and to what extent normal economic and operating conditions can resume.
Kodak's plans to return to sustainable positive cash flow include generating profitable revenues through continued pricing actions and customer-focused initiatives, investing in new product innovation to drive growth in Kodak’s businesses of print and advanced materials and chemicals, implementing effective working capital utilization, reducing operating expenses, continuing to simplify the organizational structure, investing in IT systems to drive operational efficiencies, effectively managing world-wide cash through intercompany loans, distributions or other mechanisms, generating cash from selling and leasing underutilized assets or through new licensing opportunities and implementing ways to reduce cash collateral needs.
Kodak believes its liquidity position is adequate to fund operations, meet its obligations and provide the flexibility to respond as necessary to ordinary changes in the business and economic environment within twelve months as of the filing of this Form 10-Q.
Letter of Credit Facility Agreement
Approximately $24 million of letters of credit were issued under the Amended and Restated L/C Facility Agreement as of both March 31, 2026 and December 31, 2025. The letters of credit under the Amended and Restated L/C Facility Agreement are collateralized by cash collateral (the “L/C Cash Collateral”). The L/C Cash Collateral was $26 million and $25 million at March 31, 2026 and December 31, 2025, respectively, which was classified as Restricted Cash.
Cash Flow
Cash, cash equivalents and restricted cash balances were as follows:
|
|
March 31, |
|
|
December 31, |
|
||
(in millions) |
|
2026 |
|
|
2025 |
|
||
Cash, cash equivalents and restricted cash |
|
$ |
399 |
|
|
$ |
442 |
|
Cash Flow Activity
|
|
Three Months Ended |
|
|
|
|
||||||
|
|
March 31, |
|
|
|
|
||||||
(in millions) |
|
2026 |
|
|
2025 |
|
|
Year-Over-Year Change |
|
|||
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
|
|||
Net cash used in operating activities |
|
$ |
(30 |
) |
|
$ |
(38 |
) |
|
$ |
8 |
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
|
|||
Net cash provided by (used in) investing activities |
|
|
42 |
|
|
|
(7 |
) |
|
|
49 |
|
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
|
|||
Net cash used in financing activities |
|
|
(54 |
) |
|
|
(2 |
) |
|
|
(52 |
) |
Effect of exchange rate changes on cash, cash equivalents and restricted |
|
|
(1 |
) |
|
|
2 |
|
|
|
(3 |
) |
Net decrease in cash, cash equivalents and restricted cash |
|
$ |
(43 |
) |
|
$ |
(45 |
) |
|
$ |
2 |
|
Operating Activities
Net cash used in operating activities decreased $8 million for the three months ended March 31, 2026 as compared with the corresponding period in 2025 primarily due to a decrease in trade receivables ($17 million) and trade payables ($3 million), partially offset by an increase in inventory ($23 million) and miscellaneous receivables ($7 million).
Investing Activities
Net cash provided by (used in) investing activities for the three months ended March 31, 2026 increased $49 million compared to the corresponding period in 2025 due to cash proceeds from the redemption of KRIP reversion investments ($46 million), proceeds from the sale of preferred equity investment ($2 million) and a decrease in capital expenditures ($6 million), partially offset by proceeds from the sale of assets in the prior year ($5 million).
34
Financing Activities
Net cash used in financing activities for the three months ended March 31, 2026 increased $52 million compared to the corresponding period in 2025 primarily driven by the $50 million principal repayment of the Term Loans on March 13, 2026.
Other Collateral Requirements
The NYS WCB requires security deposits related to self-insured workers’ compensation obligations, which security deposits are recalculated annually. Due to changes in 2019 to the manner in which the required security deposit is determined, the Company has been required to post additional collateral over the last several years. At December 31, 2022, the Company posted $75 million of collateral, representing 107% of the Company’s undiscounted actuarial workers’ compensation obligations. Effective May 1, 2023, the Company added New York to its existing workers compensation liability insurance policy and is no longer self-insured for future claims. As a result, the NYS WCB confirmed the Company will no longer be obligated to post any additional collateral. On July 1, 2025, the Company submitted a current actuarial report to the NYS WCB and requested a review of the collateral requirements. The NYS WCB confirmed no change in the collateral was required at this time.
Based on the legacy nature of the Company’s workers’ compensation obligations, the undiscounted actuarial obligation has been declining and the Company expects this trend to continue. While it may not be indicative of the rate of future declines, the undiscounted actuarial liability declined by an average of $5 million per year between 2014 and 2025. Accordingly, subject to the possibility of other changes to the calculation of required security deposits by the NYS WCB, the Company expects the amount of the required security deposits to decline over time and the gradual return of the security deposits that have been made or the capital used to support such security deposits.
In the third quarter of 2023, the Company deposited $68 million directly with the NYS WCB and cancelled the corresponding letter of credit supporting the associated liability. As of March 31, 2026, the Company had $50 million of surety bonds and $25 million deposited directly with the NYS WCB supporting the associated liability. The surety bonds are collateralized with $32 million of cash and the Company could be required to provide up to $18 million of cash or letters of credit to the issuers of certain surety bonds in the future to fully collateralize the bonds.
Other Uses of Cash Related to Financing Transactions
The holders of the Term Loans are entitled to quarterly cash interest payments at a rate of 12.5% which can be paid fully in cash or paid at a rate of 7.5% per annum in cash and 5.0% per annum payable in kind ("PIK") at the Company’s option (or entirely in PIK through the October 1, 2026 interest payment date). As a result of the Series B Preferred Stock Amendment, the holders are now entitled to cumulative dividends payable quarterly in cash at a rate of 6.0% per annum. All interest and dividends have been paid when due in cash.
Defined Benefit Pension and Postretirement Plans
Kodak made net contributions (funded plans) or paid benefits (unfunded plans) totaling approximately $3 million to its non-U.S. defined benefit pension and postretirement benefit plans for the three months ended March 31, 2026. For the balance of 2026, the forecasted contribution (funded plans) and benefit payment (unfunded plans) requirements for its pension and postretirement plans are approximately $6 million.
Capital Expenditures
Cash flows from investing activities included $6 million of capital expenditures for the three months ended March 31, 2026. Kodak expects approximately $45 million to $55 million of total capital expenditures for 2026.
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
Preparation of the Company’s Consolidated Financial Statements in conformity with accounting principles generally accepted in the United States (U.S. GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. The accounting policies most critical to the preparation of the consolidated financial statements and that require the most difficult, subjective or complex judgments are described in Management's Discussion and Analysis of Financial Condition and Results of Operations included in the 2025 Form 10-K. There have been no material changes in the Company's critical accounting policies or estimates since December 31, 2025.
35
Item 3. Quantitative and Qualitative Disclosures About Market Risk
As noted in the 2025 Form 10-K, Kodak operates and conducts business in many foreign countries and as a result is exposed to fluctuations between the U.S. dollar and other currencies. Volatility in the global financial markets could increase the volatility of foreign currency exchange rates which would, in turn, impact sales and net income. For a discussion of the Company's exposure to market risk and how market risk is mitigated, refer to Part I, Item 1A "Risk Factors" and Part II, Item 7A, "Quantitative and Qualitative Disclosures About Market Risk", contained in the 2025 Form 10-K.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Kodak maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in Kodak’s reports filed or submitted under the Securities Exchange Act of 1934 (the “Exchange Act”) is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to management, including Kodak’s Executive Chairman and Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. Kodak’s management, with the participation of Kodak’s Executive Chairman and Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of Kodak’s disclosure controls and procedures as of the end of the period covered by this Quarterly Report on Form 10-Q and Kodak’s Executive Chairman and Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of the period covered by this Quarterly Report on Form 10-Q, Kodak’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) were effective.
Changes in Internal Control Over Financial Reporting
Kodak is in the process of a multi-year project to modernize and enhance the Company’s global information technology systems to improve and standardize business and financial processes and to increase the efficiency and effectiveness of financial planning and reporting. As the phased implementation occurs, it may result in changes to processes and procedures which may result in changes to internal controls over financial reporting. As such changes occur, Kodak evaluates whether they materially affect the Company’s internal controls over financial reporting.
There have been no changes identified in Kodak’s internal control over financial reporting that occurred during the most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, Kodak’s internal control over financial reporting.
36
Part II. OTHER INFORMATION
Item 1. Legal Proceedings
See Note 9, “Commitments and Contingencies” in the Notes to the Financial Statements included in Part I, Item 1, “Financial Statements” for information regarding certain legal proceedings in which Kodak is involved.
Item 1A. Risk Factors
See the Risk Factors set forth in Part I, Item 1A, "Risk Factors" of the 2025 Form 10-K for a detailed discussion of risk factors that could materially affect Kodak’s business, financial condition and results of operations.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
None.
|
|
|
|
|
|
|
|
Total Number |
|
Maximum Number |
||
|
|
|
|
|
|
|
|
of Shares |
|
of Shares |
||
|
|
|
|
|
|
|
|
Purchased as |
|
That May Yet |
||
|
|
Total Number |
|
|
Average |
|
|
Part of Publicly |
|
Be Purchased |
||
|
|
of Shares |
|
|
Price Paid |
|
|
Announced Plans |
|
under the Plans or |
||
|
|
Purchased (1) |
|
|
per Share |
|
|
or Programs (2) |
|
Programs (2) |
||
January 1 through 31, 2026 |
|
|
107,885 |
|
|
$ |
7.74 |
|
|
N/A |
|
N/A |
February 1 through 28, 2026 |
|
|
59,498 |
|
|
$ |
7.56 |
|
|
N/A |
|
N/A |
March 1 through 31, 2026 |
|
|
14,554 |
|
|
$ |
7.02 |
|
|
N/A |
|
N/A |
Total |
|
|
181,937 |
|
|
$ |
7.62 |
|
|
|
|
|
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
(c) Rule 10b5-1 Trading Plans
37
Item 6. Exhibits
Eastman Kodak Company
Index to Exhibits
Exhibit Number |
|
|
|
(3.1) |
|
|
|
(3.2) |
|
|
|
(3.3) |
|
|
|
(3.4) |
|
|
|
(3.5) |
|
|
|
(3.6) |
|
|
|
(3.7) |
|
|
|
(3.8) |
|
|
|
(3.9) |
|
|
|
(4.1) |
|
|
|
(4.2) |
|
|
|
(4.3) |
|
|
|
(4.4) |
|
|
|
*(10.1) |
|
|
|
38
*(10.2) |
Eastman Kodak Company Management Bonus Plan – Functional Group (MFP), filed herewith. |
|
|
*(10.3) |
|
|
|
(10.4) |
|
|
|
(31.1) |
Certification signed by James V. Continenza, filed herewith. |
|
|
(31.2) |
Certification signed by David E. Bullwinkle, filed herewith. |
|
|
(32.1)(1) |
|
|
|
(32.2)(1) |
|
|
|
(101.INS) |
Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File as its XBRL tags are embedded within the Inline XBRL document |
|
|
(101.SCH) |
Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents |
|
|
(104) |
Cover page formatted as Inline XBRL and contained in Exhibit 101 |
* Management contract or compensatory plan or arrangement.
(1) Furnished herewith. The certifications that accompany this Quarterly Report on Form 10‑Q are not deemed filed with the SEC and are not to be incorporated by reference into any filing of the Registrant under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of this Quarterly Report on Form 10‑Q), irrespective of any general incorporation language contained in such filing.
39
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
EASTMAN KODAK COMPANY |
|
(Registrant) |
|
|
Date: May 7, 2026 |
/s/ Richard T. Michaels |
|
Richard T. Michaels |
|
Chief Accounting Officer and Corporate Controller |
|
(Chief Accounting Officer and Authorized Signatory) |
40
ATTACHMENTS / EXHIBITS
XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT